MicroPort Endovascular MedTech Ltd Cash Flow-to-Debt Ratio
MicroPort Endovascular MedTech Ltd cash flow-to-debt ratio. MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥46.79 Million could theoretically repay 0% of its total liabilities (CN¥750.07 Million) in one year. Check cash flow quality index of MicroPort Endovascular MedTech Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MicroPort Endovascular MedTech Ltd (2016–2024)
Cash flow-to-debt ratio of MicroPort Endovascular MedTech Ltd from 2016 to 2024. Historical debt coverage capacity for MicroPort Endovascular MedTech Ltd across 9 annual periods. Check 688016 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
MicroPort Endovascular MedTech Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
MicroPort Endovascular MedTech Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for MicroPort Endovascular MedTech Ltd. For the full cash flow conversion analysis, see MicroPort Endovascular MedTech Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.80x | CN¥373.60 Million | CN¥469.13 Million | ▼ -46.7% |
| 2023 | 1.49x | CN¥571.22 Million | CN¥382.63 Million | ▲ +12.9% |
| 2022 | 1.32x | CN¥333.76 Million | CN¥252.49 Million | ▲ +1.9% |
| 2021 | 1.30x | CN¥300.25 Million | CN¥231.47 Million | ▼ -15.2% |
| 2020 | 1.53x | CN¥217.44 Million | CN¥142.09 Million | ▼ -4.1% |
| 2019 | 1.60x | CN¥143.20 Million | CN¥89.74 Million | ▼ -21.4% |
| 2018 | 2.03x | CN¥106.85 Million | CN¥52.66 Million | ▲ +6.0% |
| 2017 | 1.91x | CN¥69.36 Million | CN¥36.24 Million | ▲ +314.1% |
| 2016 | 0.46x | CN¥30.13 Million | CN¥65.22 Million | — |